TREA

97373891 - IDACIO

Follow

Information

  • Trademark
  • 97373891
  • Serial Number
    97373891
  • Registration Number
    7177855
  • Filing Date
    April 21, 2022
    2 years ago
  • Registration Date
    September 26, 2023
    a year ago
  • Transaction Date
    September 26, 2023
    a year ago
  • Status Date
    September 26, 2023
    a year ago
  • Published for Opposition Date
    November 22, 2022
    2 years ago
  • Location Date
    August 21, 2023
    a year ago
  • First Use Anywhere Date
    July 01, 2023
    a year ago
  • First Use In Commerce Date
    July 01, 2023
    a year ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    STURMAN, JOSHUA M
  • Attorney Docket Number
    034175.077C
    Attorney Name
    Scott D. Woldow
    Law Office Assigned Location Code
    L30
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
IDACIO
Case File Statements
  • GS0051: Pharmaceutical preparations for human use for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections; Pharmaceutical preparations, namely, immunosuppressants; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, axial spondyloarthritis, polyarticular juvenile idiopathic arthritis and active enthesitis related arthritis, Crohn's disease, ulcerative colitis, hidradenitis colitis, hidradenitis suppurativa and non-infectious uveitis; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Biologics, namely, biological preparations for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections; Biologics, namely, biological preparations for the treatment of ankylosing spondylitis; Biological preparations for the treatment of and reducing signs and symptoms in adult patients with active ankylosing spondylitis; Protein therapeutics, namely, protein supplements; Pharmaceutical preparations for treating ankylosing spondylitis; Pharmaceutical preparations for the treatment of and for reducing signs and symptoms in adult patients with active ankylosing spondylitis; Pharmaceutical preparations for treating a wide variety of autoimmune diseases, illnesses and conditions
Case File Event Statements
  • 9/26/2023 - a year ago
    22 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 9/26/2023 - a year ago
    21 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 8/22/2023 - a year ago
    20 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 8/21/2023 - a year ago
    19 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 8/2/2023 - a year ago
    18 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 7/14/2023 - a year ago
    17 - USE AMENDMENT FILED Type: IUAF
  • 8/2/2023 - a year ago
    16 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 7/14/2023 - a year ago
    15 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 1/17/2023 - a year ago
    14 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 11/22/2022 - 2 years ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 11/22/2022 - 2 years ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 11/2/2022 - 2 years ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 10/13/2022 - 2 years ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/7/2022 - 2 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/7/2022 - 2 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/7/2022 - 2 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/12/2022 - 2 years ago
    6 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN
  • 7/12/2022 - 2 years ago
    5 - PRIORITY ACTION E-MAILED Type: GPRA
  • 7/12/2022 - 2 years ago
    4 - PRIORITY ACTION WRITTEN Type: CPRA
  • 7/5/2022 - 2 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/27/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 4/25/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP